08 Aug '11, 7am

Botox to treat European patients with bladder problems

Botox to treat European patients with bladder problems

Botox, the anti-wrinkle drug, has won a green light in Europe for treating certain patients with urinary incontinence, opening up a potentially important new market for its maker Allergan. -- PHOTO: REUTERS LONDON (REUTERS) - BOTOX, the anti-wrinkle drug, has won a green light in Europe for treating certain patients with urinary incontinence, opening up a potentially important new market for its maker Allergan . The US group said on Monday that the Irish Medicines Board had given a positive recommendation for Botox to treat patients with overactive bladder problems caused by multiple sclerosis and spinal cord injury. The move clears the way the approval of the drug in 14 countries, under the European Union's mutual recognition procedure. Botox, whose active ingredient is a toxin that blocks nerve signals, gets about half its sales from reducing wrinkles. It is also approve...

Full article: http://www.straitstimes.com/BreakingNews/TechandScience/S...

Tweets